Retinitis Pigmentosa Syndrome
2 clinical trials · Condition
◉ Watch Retinitis Pigmentosa Syndrome
| Record | Firm | Date |
|---|---|---|
| Dose Escalation Study to Evaluate the Safety/Tolerability and Efficacy of EA-2353 in Subjects With Retinitis Pigmentosa (NCT05392751) | Endogena Therapeutics, Inc | 2022-06-02 |
| Evaluation of the Visual Field on the Ground (NCT03989622) | University Hospital, Limoges | 2019-10-01 |
Track Retinitis Pigmentosa Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.